Variational AI

Variational AI, founded in September 2019, is a team of experienced artificial intelligence/machine learning researchers, drug and computational chemists who work closely with biopharmaceutical partners to apply state-of-the-art generative AI to drug discovery, redefining the unit economics of drug discovery and development. Variational AI's Enki™ platform is a foundational model for small molecule drug discovery, accelerating early-stage discovery and reducing risk.